|
1
|
Sage EK, Thakrar RM and Janes SM:
Genetically modified mesenchymal stromal cells in cancer therapy.
Cytotherapy. 18:1435–1445. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sharpe M and Mount N: Genetically modified
T cells in cancer therapy: Opportunities and challenges. Dis Model
Mech. 8:337–350. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jung KW, Won YJ, Kong HJ, Oh CM, Cho H,
Lee DH and Lee KH: Cancer statistics in korea: Incidence,
mortality, survival, and prevalence in 2012. Cancer Res Treat.
47:127–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Runowicz CD, Leach CR, Henry NL, Henry KS,
Mackey HT, Cowens-Alvarado RL, Cannady RS, Pratt-Chapman ML, Edge
SB, Jacobs LA, et al: American cancer society/american society of
clinical oncology breast cancer survivorship care guideline. J Clin
Oncol. 34:611–635. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Overbeek A, van den Berg MH, van Leeuwen
FE, Kaspers GJ, Lambalk CB and van Dulmen-den Broeder E:
Chemotherapy-related late adverse effects on ovarian function in
female survivors of childhood and young adult cancer: A systematic
review. Cancer Treat Rev. 53:10–24. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Davoodi S, Mohammadzadeh Z and Safdari R:
Mobile phone based system opportunities to home-based managing of
chemotherapy side effects. Acta Inform Med. 24:193–196. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Crozier A, Burns J, Aziz AA, Stewart AJ,
Rabiasz HS, Jenkins GI, Edwards CA and Lean ME: Antioxidant
flavonols from fruits, vegetables and beverages: Measurements and
bioavailability. Biol Res. 33:79–88. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
López-Lázaro M: Distribution and
biological activities of the flavonoid luteolin. Mini Rev Med Chem.
9:31–59. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Somerset SM and Johannot L: Dietary
flavonoid sources in australian adults. Nutr Cancer. 60:442–449.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee YJ, Lim T, Han MS, Lee SH, Baek SH,
Nan HY and Lee C: Anticancer effect of luteolin is mediated by
downregulation of TAM receptor tyrosine kinases, but not
interleukin-8, in non-small cell lung cancer cells. Oncol Rep.
37:1219–1226. 2017.PubMed/NCBI
|
|
11
|
Yan H, Wei P, Song J, Jia X and Zhang Z:
Enhanced anticancer activity in vitro and in vivo of luteolin
incorporated into long-circulating micelles based on DSPE-PEG2000
and TPGS. J Pharm Pharmacol. 68:1290–1298. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jia Z, Nallasamy P, Liu D, Shah H, Li JZ,
Chitrakar R, Si H, McCormick J, Zhu H, Zhen W and Li Y: Luteolin
protects against vascular inflammation in mice and
tnf-alpha-induced monocyte adhesion to endothelial cells via
suppressing IΚBα/NF-κB signaling pathway. J Nutr Biochem.
26:293–302. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tang X, Wang H, Fan L, Wu X, Xin A, Ren H
and Wang XJ: Luteolin inhibits Nrf2 leading to negative regulation
of the Nrf2/ARE pathway and sensitization of human lung carcinoma
A549 cells to therapeutic drugs. Free Radic Biol Med. 50:1599–1609.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shi RX, Ong CN and Shen HM: Luteolin
sensitizes tumor necrosis factor-alpha-induced apoptosis in human
tumor cells. Oncogene. 23:7712–7721. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yee SB, Choi HJ, Chung SW, Park DH, Sung
B, Chung HY and Kim ND: Growth inhibition of luteolin on hepG2
cells is induced via p53 and Fas/Fas-ligand besides the TGF-β
pathway. Int J Oncol. 47:747–754. 2015.PubMed/NCBI
|
|
16
|
Attoub S, Hassan AH, Vanhoecke B, Iratni
R, Takahashi T, Gaben AM, Bracke M, Awad S, John A, Kamalboor HA,
et al: Inhibition of cell survival, invasion, tumor growth and
histone deacetylase activity by the dietary flavonoid luteolin in
human epithelioid cancer cells. Eur J Pharmacol. 651:18–25. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang SF, Yang WE, Chang HR, Chu SC and
Hsieh YS: Luteolin induces apoptosis in oral squamous cancer cells.
J Dent Res. 87:401–406. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tang L, Li Y, Chen WY, Zeng S, Dong LN,
Peng XJ, Jiang W, Hu M and Liu ZQ: Breast cancer resistance
protein-mediated efflux of luteolin glucuronides in HeLa cells
overexpressing UDP-glucuronosyltransferase 1A9. Pharm Res.
31:847–860. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cheng AC, Huang TC, Lai CS, Kuo JM, Huang
YT, Lo CY, Ho CT and Pan MH: Pyrrolidine dithiocarbamate inhibition
of luteolin-induced apoptosis through up-regulated phosphorylation
of Akt and caspase-9 in human leukemia HL-60 cells. J Agric Food
Chem. 54:4215–4221. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pereira DM, Valentão P, Correia-da-Silva
G, Teixeira N and Andrade PB: Translating endoplasmic reticulum
biology into the clinic: A role for ER-targeted natural products?
Nat Prod Rep. 32:705–722. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang K and Kaufman RJ: From
endoplasmic-reticulum stress to the inflammatory response. Nature.
454:455–462. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rutkowski DT and Kaufman RJ: A trip to the
ER: Coping with stress. Trends Cell Biol. 14:20–28. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Walter P and Ron D: The unfolded protein
response: From stress pathway to homeostatic regulation. Science.
334:1081–1086. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mori K: Signalling pathways in the
unfolded protein response: Development from yeast to mammals. J
Biochem. 146:743–750. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Noble JE: Quantification of protein
concentration using UV absorbance and Coomassie dyes. Methods
Enzymol. 536:17–26. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin LC, Pai YF and Tsai TH: Isolation of
luteolin and luteolin-7-O-glucoside from dendranthema morifolium
ramat Tzvel and their pharmacokinetics in rats. J Agric Food Chem.
63:7700–7706. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cai X, Lu W, Ye T, Lu M, Wang J, Huo J,
Qian S, Wang X and Cao P: The molecular mechanism of
luteolin-induced apoptosis is potentially related to inhibition of
angiogenesis in human pancreatic carcinoma cells. Oncol Rep.
28:1353–1361. 2012.PubMed/NCBI
|
|
28
|
Tuorkey MJ: Molecular targets of luteolin
in cancer. Eur J Cancer Prev. 25:65–76. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Flusberg DA and Sorger PK: Surviving
apoptosis: Life-death signaling in single cells. Trends Cell Biol.
25:446–458. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen L, Li Q, She T, Li H, Yue Y, Gao S,
Yan T, Liu S, Ma J and Wang Y: IRE1α-XBP1 signaling pathway, a
potential therapeutic target in multiple myeloma. Leuk Res.
49:7–12. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Axten JM: Protein kinase R (PKR)-like
endoplasmic reticulum kinase (PERK) inhibitors: A patent review
(2010–2015). Expert Opin Ther Pat. 27:37–48. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kimata Y and Kohno K: Endoplasmic
reticulum stress-sensing mechanisms in yeast and mammalian cells.
Curr Opin Cell Biol. 23:135–142. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Welihinda AA, Tirasophon W and Kaufman RJ:
The cellular response to protein misfolding in the endoplasmic
reticulum. Gene Expr. 7:293–300. 1999.PubMed/NCBI
|
|
34
|
Moreno JA and Tiffany-Castiglioni E: The
chaperone Grp78 in protein folding disorders of the nervous system.
Neurochem Res. 40:329–335. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dandekar A, Mendez R and Zhang K: Cross
talk between ER stress, oxidative stress, and inflammation in
health and disease. Methods Mol Biol. 1292:205–214. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Breckenridge DG, Germain M, Mathai JP,
Nguyen M and Shore GC: Regulation of apoptosis by endoplasmic
reticulum pathways. Oncogene. 22:8608–8618. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Szegezdi E, Logue SE, Gorman AM and Samali
A: Mediators of endoplasmic reticulum stress-induced apoptosis.
EMBO Rep. 7:880–885. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Clarke HJ, Chambers JE, Liniker E and
Marciniak SJ: Endoplasmic reticulum stress in malignancy. Cancer
Cell. 25:563–573. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Martins AS, Alves I, Helguero L, Domingues
MR and Neves BM: The unfolded protein response in homeostasis and
modulation of mammalian immune cells. Int Rev Immunol. 35:457–476.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Vanhaesebroeck B, Stephens L and Hawkins
P: PI3K signalling: The path to discovery and understanding. Nat
Rev Mol Cell Biol. 13:195–203. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ohsaka Y and Nomura Y: Rat white
adipocytes activate p85/p110 PI3K and induce PM GLUT4 in response
to adrenoceptor agonists or aluminum fluoride. Physiol Int.
103:35–48. 2016.PubMed/NCBI
|
|
42
|
Vogt PK, Hart JR, Gymnopoulos M, Jiang H,
Kang S, Bader AG, Zhao L and Denley A: Phosphatidylinositol
3-kinase: The oncoprotein. Curr Top Microbiol Immunol. 347:79–104.
2010.PubMed/NCBI
|
|
43
|
Park SW, Zhou Y, Lee J, Lu A, Sun C, Chung
J, Ueki K and Ozcan U: The regulatory subunits of PI3K, p85alpha
and p85beta, interact with XBP-1 and increase its nuclear
translocation. Nature Med. 16:429–437. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Stefani IC, Wright D, Polizzi KM and
Kontoravdi C: The role of ER stress-induced apoptosis in
neurodegeneration. Curr Alzheimer Res. 9:373–387. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lee WS, Yoo WH and Chae HJ: ER stress and
autophagy. Curr Mol Med. 15:735–745. 2015. View Article : Google Scholar : PubMed/NCBI
|
